Q1 2024 13F Holders as of 31 Mar 2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
192,975,286
-
Total 13F shares
-
186,676,383
-
Share change
-
+763,479
-
Total reported value
-
$16,305,278,098
-
Put/Call ratio
-
102%
-
Price per share
-
$87.34
-
Number of holders
-
550
-
Value change
-
+$52,133,744
-
Number of buys
-
255
-
Number of sells
-
252
Institutional Holders of BIOMARIN PHARMACEUTICAL INC - Common Stock (BMRN) as of Q1 2024
As of 31 Mar 2024,
BIOMARIN PHARMACEUTICAL INC - Common Stock (BMRN) was held by
550 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
186,676,383 shares.
The largest 10 holders included
PRIMECAP MANAGEMENT CO/CA/, VANGUARD GROUP INC, BlackRock Inc., Dodge & Cox, STATE STREET CORP, Capital Research Global Investors, VIKING GLOBAL INVESTORS LP, AMERIPRISE FINANCIAL INC, BARCLAYS PLC, and UBS Group AG.
This page lists
550
institutional shareholders reporting positions in this security
for the Q1 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.